| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/13/2000 | WO1999055312A3 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
| 01/13/2000 | WO1999053953A3 Methods and products related to metabolic interactions in disease |
| 01/13/2000 | WO1999052936A3 Arginine peptide analogs useful as fibroblast growth factor antagonists |
| 01/13/2000 | WO1999051259A3 Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines |
| 01/13/2000 | WO1999050252A3 Barbituric acid derivative and preventive and therapeutic agent for bone and cartilage containing the same |
| 01/13/2000 | WO1999049716A3 Method for producing liposomal formulations of active agents by high-pressure homogenisation |
| 01/13/2000 | WO1999043309A3 Anticonvulsant drugs and pharmaceutical compositions thereof |
| 01/13/2000 | WO1999038501A3 Method of regulating glucose metabolism, and reagents related thereto |
| 01/13/2000 | WO1999029640A3 Compositions and methods for modulating the activity of fibroblast growth factor |
| 01/13/2000 | WO1999018941A3 Ih-MODULATORS |
| 01/13/2000 | WO1998049177A8 Anti-viral pyrimidine nucleoside analogues |
| 01/13/2000 | DE19929994A1 Treatment of skeletal muscle dystrophies and atrophies using creatine |
| 01/13/2000 | DE19920966A1 alpha-Ketoamidderivate alpha-Ketoamidderivate |
| 01/13/2000 | DE19830768A1 Creatine-containing comprises neurotransmitter and alpha-liponic acid useful for treating muscular dystrophy and for preventing obesity in muscular dystrophy sufferers |
| 01/13/2000 | DE19830732A1 Zusammensetzung, enthaltend mindestens einen die Blutfettwerte beeinflussenden Wirkstoff A composition comprising at least one lipid levels influencing drug |
| 01/13/2000 | DE19830651A1 Steroidhaltiges Pflaster, Verfahren zu seiner Herstellung und Verwendung Steroid-containing patch, process for its preparation and use |
| 01/13/2000 | DE19830649A1 Topisches Pflaster mit nichtsteroidalen Antirheumatika mit Säuregruppe The topical patch with NSAIDs with acid group |
| 01/13/2000 | DE19830648A1 Glyceroltrinitrathaltige Zusammensetzung, Verfahren zu ihrer Herstellung und ihre Verwendung Glyceroltrinitrathaltige composition, process for their preparation and their use |
| 01/13/2000 | DE19830431A1 Sulfonylamino-carbonsäure-N-arylamide als Guanylatcyclase-Aktivatoren Sulfonylamino-carboxylic acid N-arylamides as guanylate cyclase activators |
| 01/13/2000 | DE19830430A1 New sulfur-substituted sulfonylamino-carboxylic acid N-arylamide derivatives useful as guanylate cyclase activators in treatment of e.g. cardiovascular disorders, asthma and diabetes |
| 01/13/2000 | DE19830246A1 Pharmazeutische Zubereitung Pharmaceutical composition |
| 01/13/2000 | DE19830201A1 Mittel mit antidepressiver Wirkung Agent with an antidepressant activity |
| 01/13/2000 | DE19830081A1 Use of substituted thione compounds as nitric oxide synthase activators |
| 01/13/2000 | DE19829908A1 Use of known and new pentaerythritol derivatives as analytical substrates and medicaments, e.g. for treatment of cardiovascular disorders |
| 01/13/2000 | CA2831321A1 Production of isoprenoid in recombinant yeast |
| 01/13/2000 | CA2658200A1 Naaladase inhibitors useful as pharmaceutical compounds and compositions |
| 01/13/2000 | CA2402839A1 Galectin 11 |
| 01/13/2000 | CA2379524A1 Salts and bases of the 17-(cyclopropylmethyl)-4,5 alpha-epoxy-6-methylenemorphinan-3,14 diol molecule for optimizing dopamine homeostasis during administration of opiod analgesics |
| 01/13/2000 | CA2356841A1 Substituted nitrogen and sulfur alicyclic compounds, including methods for synthesis thereof |
| 01/13/2000 | CA2345919A1 Substituted oxygen alicyclic compounds, including methods for synthesis thereof |
| 01/13/2000 | CA2337273A1 Thixotropic formulations for filling capsules |
| 01/13/2000 | CA2337059A1 Piperazine derivatives inhibiting human immunodeficiency virus replication |
| 01/13/2000 | CA2336894A1 New benzoxazoles with pde-inhibiting activity |
| 01/13/2000 | CA2336774A1 Angiogenesis inhibitors |
| 01/13/2000 | CA2336714A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 01/13/2000 | CA2336475A1 Inhibitors of prenyl-protein transferase |
| 01/13/2000 | CA2336470A1 Salts of paroxetine |
| 01/13/2000 | CA2336448A1 Inhibitors of prenyl-protein transferase |
| 01/13/2000 | CA2336419A1 Novel indolocarbazole derivatives useful for the treatment of neurodegenerative diseases and cancer |
| 01/13/2000 | CA2336384A1 Oligonucleotide inhibitors of bcl-xl |
| 01/13/2000 | CA2336363A1 Fermentation process to produce clavulanic acid at a low concentration of free amino acids |
| 01/13/2000 | CA2336315A1 Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| 01/13/2000 | CA2336300A1 Substituted .beta.-diketones and their use |
| 01/13/2000 | CA2336134A1 Use of texaphyrins in macrophage-mediated disease |
| 01/13/2000 | CA2336054A1 Inhibitors of prenyl-protein transferase |
| 01/13/2000 | CA2335967A1 Process for producing (8- chloro-3,10- dibromo-6,11- dihydro- 5h-benzo ¬5,6|cyclohepta ¬1,2-b|pyridin-11-yl)- 1-piperidine |
| 01/13/2000 | CA2335824A1 Therapeutic system with addition of nacreous pigments |
| 01/13/2000 | CA2335503A1 Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and alkanoyl l-carnitines |
| 01/13/2000 | CA2335148A1 Water-soluble native dry plant extract, especially ginkgo biloba extract with a high terpenoid and flavone glycoside content |
| 01/13/2000 | CA2332699A1 Antisense oligonucleotides targeted to il-15 |
| 01/13/2000 | CA2331829A1 Kv6.2, a voltage-gated potassium channel subunit |
| 01/13/2000 | CA2331343A1 Production of isoprenoid in recombinant yeast |
| 01/13/2000 | CA2301510A1 3-alkylpyrrolo[3,2-c]quinoline derivatives |
| 01/13/2000 | CA2276765A1 Disposable monomer dispenser and vial breaker |
| 01/12/2000 | EP0970957A1 Diaza-spiro[3,5] nonane derivatives |
| 01/12/2000 | EP0970955A1 Paroxetine methanesulfonate |
| 01/12/2000 | EP0970954A1 3-piperidyl-4-oxoquinazoline derivatives and medicincal compositions containing the same |
| 01/12/2000 | EP0970950A2 Novel isoxazoline and isoxazole fibrinogen receptor antagonists |
| 01/12/2000 | EP0970949A1 Acridine derivatives |
| 01/12/2000 | EP0970700A2 Gallium containing medicaments for enhancing wound healing and tissue repair |
| 01/12/2000 | EP0970698A1 Use of D-galactose for preventing necrosis |
| 01/12/2000 | EP0970696A1 Combination of loop diuretics with adenosine A1-receptor antagonists |
| 01/12/2000 | EP0970695A1 Methods for increasing levels of acetylcholine |
| 01/12/2000 | EP0970694A2 Use of carprofen and derivatives therof for treating or preventing articular degeneration |
| 01/12/2000 | EP0970693A1 Biologically active labdane or labdene derivatives from Cistus |
| 01/12/2000 | EP0970692A1 Novel cosmetic compositions containing a filmforming polymer |
| 01/12/2000 | EP0970243A1 Diagnosis and treatment of glaucoma |
| 01/12/2000 | EP0970232A2 Non-immunogenic prodrugs and selectable markers for use in gene therapy |
| 01/12/2000 | EP0970218A1 Variants of vascular endothelial cell growth factor having altered pharmacological properties, and related aspects thereof |
| 01/12/2000 | EP0970203A2 Agents for pre-symptomatic detection and therapeutic targeting of alzheimer's disease and down syndrome in humans |
| 01/12/2000 | EP0970198A2 Novel compounds |
| 01/12/2000 | EP0970195A1 Fatty-acid amide hydrolase |
| 01/12/2000 | EP0970186A1 SpoOJ2 OF STAPHYLOCOCCUS AUREUS |
| 01/12/2000 | EP0970130A2 Glycosaminoglycans having high antithrombotic activity |
| 01/12/2000 | EP0970127A1 Antibody variants |
| 01/12/2000 | EP0970115A1 Viral peptides with structural homology to protein g of respiratory syncytial virus |
| 01/12/2000 | EP0970114A1 Neoglycoproteins |
| 01/12/2000 | EP0970105A1 Process for preparing carboxamido-4-azasteroids |
| 01/12/2000 | EP0970104A2 Steroid sulfamates, method for the production and use thereof |
| 01/12/2000 | EP0970103A1 Antigestagenic steroids with a fluorinated 17alpha-alkyl chain |
| 01/12/2000 | EP0970100A1 Benzimidazole derivatives |
| 01/12/2000 | EP0970098A1 Anthracycline glycosides |
| 01/12/2000 | EP0970095A1 Novel benzimidazole inhibitors of fructose-1,6-bisphosphatase |
| 01/12/2000 | EP0970090A1 Substituted 4-arylmethylene-2-imino-2,3-dihydrothiazoles and derivatives and their pharmaceutical use |
| 01/12/2000 | EP0970089A2 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action |
| 01/12/2000 | EP0970088A2 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha1-blocking action |
| 01/12/2000 | EP0970084A1 Pyrrolo 2,3d]pyrimidines and their use as tyrosine kinase inhibitors |
| 01/12/2000 | EP0970083A1 7a-HETEROCYCLE-SUBSTITUTED HEXAHYDRO-1H-PYRROLIZINE COMPOUNDS USEFUL IN CONTROLLING CHEMICAL SYNAPTIC TRANSMISSION |
| 01/12/2000 | EP0970082A2 Biazacyclic crf antagonists |
| 01/12/2000 | EP0970081A1 Substituted (1,3-bis(cyclohexylmethyl)-1,2,3,6-tetrahydro-2,6-dioxo-9h-purin-8-yl)phenyl derivatives, their preparation and their use in the treatment of inflammatory conditions and immune disorders |
| 01/12/2000 | EP0970080A1 Imino-aza-anthracyclinone derivatives for the treatment of amyloidosis |
| 01/12/2000 | EP0970079A1 Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with n- or c-linked imidazoles |
| 01/12/2000 | EP0970077A1 Improved method for producing thiazolidinediones, and new thiazolidinediones |
| 01/12/2000 | EP0970076A1 7-[(piperidin-1-yl)- propoxy]-chromen-4-one derivatives, their preparation and their pharmaceutical use |
| 01/12/2000 | EP0970075A1 Pyrimidinone-1,3-oxathiolane derivatives with antiviral activity |
| 01/12/2000 | EP0970073A1 Process for preparing eprosartan |
| 01/12/2000 | EP0970070A1 Phthalazines with angiogenesis inhibiting activity |
| 01/12/2000 | EP0970067A1 (methylsulfonyl)phenyl-2-(5h)-furanones with oxygen link as cox-2 inhibitors |
| 01/12/2000 | EP0970062A2 Pyrrolidine and thiazole derivatives with metallo-beta-lactamase inhibitory properties |
| 01/12/2000 | EP0970060A1 Lta 4 hydrolase inhibitors |